Efficacy of omalizumab for the treatment of bullous pemphigoid: Spanish multicentre real-world experience.
Álvaro Aguado VázquezAndrea Estébanez CorralesF Javier Melgosa RamosJosé Manuel Mascaró GalyJon Fulgencio-BarbarinXavier Bosch AmateLaia Curto BarredoMar Blanes-MartínezRicardo Ruiz VillaverdeAsunción Ballester MartínezDaniel Martín-TorregrosaJuan Luis Castaño FernándezRita Cabeza MartínezAmparo Pérez-FerriolsDaniel Ramos RodríguezJulian Boix VilanovaGemma Melé-NinotVicente Expósito SerranoAgustin España AlonsoAlmudena Mateu-PuchadesPublished in: Clinical and experimental dermatology (2024)
Omalizumab is a good therapeutic alternative for BP as it provided clinical response in most patients, and nearly one-half of the cases achieved complete response. It showed no side-effects, which is crucial in older patients with BP.